Kyle Moran, Chief Financial Officer at Wave Life Sciences Ltd. (WVE), sold 74,124 shares at $4.75 ($352K) on 2023-08-23, disclosed to the SEC on 2023-08-23.
Scheduled sale ($352k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.75 | 37,062 | $176K | 50.0% |
| 2 | $4.75 | 37,062 | $176K | 50.0% |
| Total | $4.75 avg | 74,124 | $352K | 100% |
| Filing → |
| WVE | SELL | 2024-09-27 | $154K | — | Filing → |
| WVE | SELL | 2024-04-05 | $193K | — | Filing → |
| WVE | SELL | 2023-02-17 | $39K | — | Filing → |